Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

A new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...

Residents across the St. Louis region may have trouble sleeping Friday night as the year's first severe storm risk is ...

Key Insights Significantly high institutional ownership implies Legal & General Group's stock price is sensitive ...

Autolus Therapeutics PLC (AUTL) reports significant progress ... in San Diego. “The FELIX study’s rich data set continues to provide important information in shaping our understanding of ...

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Satellites come in all shapes and sizes, but there aren't any that look quite like SPHEREx, an infrared observatory NASA ...

With their music continuing to entertain fans all over the world, Pearson recently passed away at 60 years old. Dealing with several health issues over the recent years, Pearson suffered from diabetes ...

Investing.com -- Shares of MeiraGTx Holdings plc (Nasdaq: NASDAQ: MGTX) climbed 13% following the announcement of a strategic collaboration with Hologen AI, aimed at accelerating the Phase 3 ...

A group of bipartisan US Congressmen want to establish a commission to study the creation of a National Museum of Irish ...